Charles Schwab Investment Management Inc Nuvation Bio Inc. Transaction History

Charles Schwab Investment Management Inc

$557 Billion
Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 2,130,899 shares of NUVB stock, worth $7.88 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,130,899

Previous 1,904,141 11.91%

Holding current value

$7.88 Million

Previous $3.35 Million 23.99%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$1.66 - $2.53 $376,418 - $573,697	226,758 Added 11.91%	2,130,899 $4.16 Million
Q1 2025 Sep 15, 2025	SELL	$1.76 - $3.25 $399,094 - $736,963	-226,758 Reduced 10.64%	1,904,141 $3.35 Million
Q1 2025 May 09, 2025	SELL	$1.76 - $3.25 $73,641 - $135,986	-41,842 Reduced 2.15%	1,904,141 $3.35 Million
Q4 2024 Feb 06, 2025	BUY	$2.01 - $3.01 $1.11 Million - $1.66 Million	551,968 Added 39.6%	1,945,983 $5.18 Million
Q3 2024 Nov 12, 2024	BUY	$2.3 - $3.83 $139,357 - $232,059	60,590 Added 4.54%	1,394,015 $3.21 Million
Q2 2024 Aug 12, 2024	BUY	$2.58 - $3.69 $478,326 - $684,118	185,398 Added 16.15%	1,333,425 $3.89 Million
Q1 2024 May 08, 2024	BUY	$1.46 - $3.97 $31,191 - $84,815	21,364 Added 1.9%	1,148,027 $4.18 Million
Q4 2023 Feb 06, 2024	BUY	$0.96 - $1.53 $81,129 - $129,300	84,510 Added 8.11%	1,126,663 $1.7 Million
Q3 2023 Nov 08, 2023	BUY	$1.26 - $2.1 $2,977 - $4,962	2,363 Added 0.23%	1,042,153 $1.4 Million
Q2 2023 Aug 09, 2023	BUY	$1.56 - $1.84 $134,142 - $158,219	85,989 Added 9.02%	1,039,790 $1.87 Million
Q1 2023 May 11, 2023	BUY	$1.6 - $2.48 $105,080 - $162,874	65,675 Added 7.39%	953,801 $1.58 Million
Q4 2022 Feb 13, 2023	SELL	$1.68 - $2.5 $125,356 - $186,542	-74,617 Reduced 7.75%	888,126 $1.71 Million
Q3 2022 Nov 14, 2022	BUY	$0.29 - $4.04 $40,181 - $559,774	138,558 Added 16.81%	962,743 $2.16 Million
Q2 2022 Aug 15, 2022	SELL	$3.24 - $5.85 $378,600 - $683,584	-116,852 Reduced 12.42%	824,185 $2.67 Million
Q1 2022 May 13, 2022	BUY	$4.6 - $8.83 $153,474 - $294,604	33,364 Added 3.68%	941,037 $4.95 Million
Q4 2021 Feb 11, 2022	BUY	$7.75 - $10.05 $1.64 Million - $2.13 Million	212,255 Added 30.52%	907,673 $7.72 Million
Q3 2021 Nov 16, 2021	BUY	$7.78 - $10.0 $2.47 Million - $3.18 Million	317,882 Added 84.2%	695,418 $6.91 Million
Q2 2021 Aug 16, 2021	BUY	$9.22 - $14.48 $756,888 - $1.19 Million	82,092 Added 27.79%	377,536 $3.52 Million
Q1 2021 May 17, 2021	BUY	$9.0 - $14.57 $2.66 Million - $4.3 Million	295,444 New	295,444 $3.09 Million

Others Institutions Holding NUVB

# of Institutions

195

Shares Held

168M

Call Options Held

2.31M

Put Options Held

221K

View Full List

About Nuvation Bio Inc.

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $804M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

More about NUVB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Nuvation Bio Inc. Transaction History